Direct to Consumer (DTC) pharmaceutical advertising recall: The role of involvement
DOI:
https://doi.org/10.58997/smc.v32i1.26Abstract
The effect of different amounts of risk information in DTC ads on recall was examined in an experiment. Three versions of DTC ads, containing different amounts of risk information were developed based on FDA guidelines and shown to participants in a 3 x 3 between group design. Participants’ unaided recall of ad information suggest a main effect of ad version on recall, with the ads that have moderate amount of risk information eliciting the most recall of risk information. The moderating role of involvement was inconclusive. Since the Food and Drug Administration (FDA) eased restrictions on Direct to Consumer (DTC) advertising of prescription drugs in the 1980s, the debate regarding appropriate risk disclosures that would enable consumers make accurate assessment of drugs continues. At the core is what risk disclosure formats lead to adequate recall of risk information. This paper explores the role of involvement in recall of risk disclosures in print ads containing varying amounts of risk information. This exploratory study uses experimental methodology and helps provide preliminary insights into this important issue. Findings from this study could serve as a basis for developing larger studies to examine this issue in more depth to reach actionable conclusions that would inform policy recommendations on what level of risk disclosure should be encouraged to achieve the desired levels of risk information recall.References
Arnold, M. (2006). Merck taps DDB, Ogilvy for DTC risk-recall research. Medical Marketing & Media, 41(8), 10.
Baack, D., Wilson, R. T., & Till, B. D. (2012). Creativity and memory effects: Recall, Recognition, and an Exploration of Nontraditional Media, Journal of Advertising, vol. 37, 4, 85–94.
Cacioppo, J. T., Petty, R. E., & Kao, C. F. (1984). The efficient assessment of need for cognition. Journal of Personality Assessment. 48, 306-307.
Celsi, R. L., & Olson, J. C. (1988). The role of involvement in attention and comprehension processes. Journal of Consumer Research, 15, 210-224.
Davis, J. J. (2007). Consumers’ preferences for the communication of risk information in drug advertising. Health Affairs, 26 (3), 863-870.
Davis, J. J. (2000). Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised drugs. Journal of Health Communication, 5, 349-369.
FDA (n.d.). Prescription drug advertising: questions and answers. Retrieved from http://www.fda.gov/Drugs/ResourcesForYou/Consumers/PrescriptionDrugAdvertising/uc m076768.htm
FDA (2004). Brief summary: Disclosing risk information in consumer-directed print advertisements. Draft guidance. Retrieved from http://www.fda.gov/cder/guidance/index.htm
Gotlieb, J. B., & Sarel, D. (1991). Comparative advertising effectiveness: The role of involvement and source credibility. Journal of Advertising, 20, 38-45.
Harker, M. & Harker, D. (2007). Direct-to-consumer advertising of prescription medicines: a systematic review of the evidence from the perspective of the consumer”, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 7 45-54.
Holtz, W. (1998). Consumer-directed prescription drug advertising: Effects on public health. Journal of Law and Health, 13, 199-218.
Iyer, N. & Feng, Y. (2011). Impact of modality congruence and visual dominance on recall of disclosures in DTC commercials. Proceeding of the conference – American Academy of Advertising, 33-41
Jeong, Y., Kim, Y. & Zhao, X. (2011). Competing for consumer memory in television advertising: an empirical examination of the impacts of non-editorial clutter on brand memory in mega-event broadcasts. International Journal of Advertising, 30, 617–640.
Lyles, A. (2002). Direct marketing of pharmaceuticals to consumers. Annual Review of Public Health, 23, 73-91.
Morris, L. A., Brinberg, D., Klimberg, R., Rivera, C., & Millstein, L. G. (1986). Consumer attitudes about advertisements for medicinal drugs. Social Science Medicine, 222, 629638.
Morris, L. A., Brinberg, D., & Plimpton, L. (1984). Prescription drug information for consumers: An experiment of source and format. Current Issues and Research in Advertising, 7, 6578.
Morris, L. A., Mazis, M. B., & Brinberg, D. (1989). Risk disclosures in televised prescription drug advertising to consumers. Journal of Public Policy and Marketing, 8, 64-80.
Morris, L. A., Ruffner, M., & Klimberg, R. (1985). Warning disclosures for prescription drugs. Journal of Advertising Research, 25, 25-32.
Machleit, K. A., Allen, C., & Madden, T. (1993). The mature brand and brand interest: An alternative consequence of ad-evoked affect. Journal of Marketing, 57(4), 72-82.
Martin, N. & Prince, D. (2010). Journal of Management and Marketing Research, vol 4, 1-15.
Petty, R.E., & Cacioppo, J. T. (1979). Issue involvement can increase or decrease persuasion by enhancing message relevant cognitive responses. Journal of Personality and Social Psychology, 37, 1915-1926.
Putrevu, S., Tan, J., & Lord, K. R. (2004). Consumer responses to complex advertisements: The moderating role of need for cognition, knowledge, and gender. Journal of Current Issues and Research in Advertising. 26, 9-23
Rothschild, M.L. & Churchill, Jr, G.A. (1988) Recognition versus recall as measures of television commercial forgetting. Journal of Marketing Research, 25(1), 72–81.
Schommer, J. C., Doucette, W. R., & Mehta, B. H. (1998). Rote learning after exposure to direct-to-consumer television advertisements for a prescription drug. Clinical Therapeutics, 20, 617-632.
Rajaram, S., Srinivas, K., & Travers, S. (2001). The effects of attention on perceptual implicit memory. Memory & Cognition, 29(7), 920.
Wilson, R.T. and Till, B.D. (2007), “Direct-to-consumer pharmaceutical advertising: building and testing a model for advertising effectiveness”, Journal of Advertising Research, Vol. 47 No. 3, p. 270.
Wilkes, M. S., Bell, R. A., & Kravitz, R. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19, 110-128.
Zaichkowsky, J. L. (1994). The personal involvement inventory: Reduction, revision, and application to advertising. Journal of Advertising, 23, 59-70.
